Alcohol Metabolic Inefficiency: Structural Characterization of Polymorphism-Induced ALDH2 Dysfunctionality and Allosteric Site Identification for Design of Potential Wildtype Reactivators

  • Emmanuel A. Adeniji
  • Fisayo A. Olotu
  • Mahmoud E. S. Soliman
Article
  • 11 Downloads

Abstract

Liver mitochondrial aldehyde dehydrogenase 2 (ALDH2) enzyme is responsible for the rapid conversion of acetaldehyde to acetic acid. ALDH2 (E487K) polymorphism results in an inactive allele (ALDH2*2) which cause dysfunctional acetaldehyde metabolism. The 3D structure of an enzyme is crucial to its functionality and a disruption in its structural integrity could result in its metabolic inefficiency and dysfunctionality. Allosteric targeting of polymorphs could facilitate the restoration of wildtype functionalities in ALDH2 polymorphs and serve as an advancement in the treatment of associated diseases. Therefore, structural insights into ALDH2*2 polymorph could reveal the varying degree of alterations which occur at its critical domains and accounts for enzymatic dysfunctionality. In this study, we report the structural characterization of ALDH2*2 polymorph and its critical domains using computational tools. Our findings revealed that the polymorph exhibited significant alterations in stability and flexibility at the catalytic and co-enzyme-binding domain. Moreover, there was an increase in the solvent-exposed surface residues and this indicates structural perturbations. Analysis of the interaction network at ALDH2*2 catalytic domain revealed residual displacement and interaction loss when compared to the wildtype thereby providing insight into the catalytic inefficiency of the polymorph. Interestingly, perturbations induced by ALDH2 polymorphism involves the re-orientation of surface residues, which resulted in the formation of surface exposed pockets. These identified pockets could be potential sites for allosteric targeting. The findings from this study will aid the design of novel site-specific small molecule reactivators with the propensity of restoring wildtype activities for treatment of polymorphic ALDH2 related diseases.

Keywords

Alcohol Aldehyde dehydrogenase Polymorphism Carcinogenesis Metabolism dysfunctionality 

Notes

Acknowledgements

I want to express my appreciation to the research colleagues in the Laboratory. My profound gratitude goes to my supervisor for his relentless support during this work.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Zakhari S (2006) Overview: how is alcohol metabolized by the body?. Alcohol Res Health 29(4):245–254Google Scholar
  2. 2.
    Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V et al (2007) Carcinogenicity of alcoholic beverages. Lancet Oncol 8(4):292–293CrossRefGoogle Scholar
  3. 3.
    Larson HN, Weiner H, Hurley TD (2005) Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase “Asian” variant. J Biol Chem 280(34):30550–30556CrossRefGoogle Scholar
  4. 4.
    Seitz HK, Stickel F (2006) Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387:349–360CrossRefGoogle Scholar
  5. 5.
    Li H, Borinskaya S, Yoshimura K, Kal’ina N, Marusin A, Stepanov VA et al (2009) Refined geographic distribution of the oriental ALDH2* 504Lys (nee 487Lys) variant. Ann Hum Genet 73(3):335–345CrossRefGoogle Scholar
  6. 6.
    Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A (2009) The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 6(3):0258–0263CrossRefGoogle Scholar
  7. 7.
    Johansson K, El-Ahmad M, Ramaswamy S, Hjelmqvist L, Jörnvall H, Eklund H (1998) Structure of betaine aldehyde dehydrogenase at 2.1 A resolution. Protein Sci. 7(10):2106–2117. Available https://onlinelibrary.wiley.com/doi/abs/10.1002/pro.5560071007
  8. 8.
    Case D, Cheatham TE, Darden TOM, Luo R, Merz Y, Onufriev KM et al (2009) The Amber biomolecular simulation programs the amber biomolecular simulation programs. J Comput Chem 26(16):1–31Google Scholar
  9. 9.
    Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926–935. Available https://aip.scitation.org/doi/abs/10.1063/1.445869
  10. 10.
    Harvey MJ, De Fabritiis G (2009) An implementation of the smooth particle mesh Ewald method on GPU hardware. J Chem Theory Comput 5(9):2371–2377CrossRefGoogle Scholar
  11. 11.
    Berendsen HJC, Postma JPM, Gunsteren WF van, DiNola A (1998) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684CrossRefGoogle Scholar
  12. 12.
    Huang B (2009) MetaPocket: a meta approach to improve protein ligand binding site prediction. Omi A J Integr Biol 13(4):325–330CrossRefGoogle Scholar
  13. 13.
    Neal KB, Mahmoud ES (2017) Can we rely on computational predictions to correctly identify ligand binding sites on novel protein drug targets? Assessment of binding site prediction methods and a protocol for validation of predicted binding sites. Cell Biochem Biophys 75(1):15–23CrossRefGoogle Scholar
  14. 14.
    Seifert E (2014) OriginPro 9.1: Scientific data analysis and graphing software—software review. J Chem Inf Model 54:1552CrossRefGoogle Scholar
  15. 15.
    Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRefGoogle Scholar
  16. 16.
    Doncheva NT, Klein K, Domingues FS, Albrecht M (2011) Analyzing and visualizing residue networks of protein structures. Trends Biochem Sci 36:179–182CrossRefGoogle Scholar
  17. 17.
    Bhakat S, Martin AJM, Soliman MES (2014) An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine. Mol Biosyst 10(8):2215–2228CrossRefGoogle Scholar
  18. 18.
    Lazaridis T, Lee I, Karplus M (2008) Dynamics and unfolding pathways of a hyperthermophilic and a mesophilic rubredoxin. Protein Sci 6(12):2589–2605CrossRefGoogle Scholar
  19. 19.
    Bös F, Pleiss J (2009) Multiple molecular dynamics simulations of TEM beta-lactamase: dynamics and water binding of the omega-loop. Biophys J 97(9):2550–2558. Available http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2770601&tool=pmcentrez&rendertype=abstract
  20. 20.
    Salleh AB, Abd R, Arilla SM, Raja AR (2012) The role of Arg157Ser in improving the compactness and stability of ARM lipase. J Comput Sci Syst Biol 5(2):39–46CrossRefGoogle Scholar
  21. 21.
    Lobanov MI, Bogatyreva NS, Galzitskaia OV (2008) Radius of gyration is indicator of compactness of protein structure. Mol Biol (Mosk) 42(4):701–706CrossRefGoogle Scholar
  22. 22.
    Larson HN, Zhou J, Chen Z, Stamler JS, Weiner H, Hurley TD (2007) Structural and functional consequences of coenzyme binding to the inactive Asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487. J Biol Chem 282(17):12940–12950CrossRefGoogle Scholar
  23. 23.
    Sheikh S, Weiner H (1997) Allosteric inhibition of human liver aldehyde dehydrogenase by the isoflavone prunetin. Biochem Pharmacol 53(4):471–478CrossRefGoogle Scholar
  24. 24.
    Hu G, Yan W, Zhou J, Shen B (2014) Residue interaction network analysis of Dronpa and a DNA clamp. J Theor Biol 348:55–64CrossRefGoogle Scholar
  25. 25.
    Papaleo E, Pasi M, Riccardi L, Sambi I, Fantucci P, Gioia L, De (2008) Protein flexibility in psychrophilic and mesophilic trypsins: evidence of evolutionary conservation of protein dynamics in trypsin-like serine-proteases. FEBS Lett 582(6):1008–1018CrossRefGoogle Scholar
  26. 26.
    Jaume FS, Xinping W, Kojiro T, Suzanne J, Cunningham TTW (1994) Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase: a model to study human (Oriental type) class 2 aldehyde dehydrogenase. J Biol Chem 19:13854–13860Google Scholar
  27. 27.
    Akira Y, I-Yih H, Michiharu I (1984) Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in orientals (inactive mutant enzyme/alcohol sensitivity/polymorphism). Proc Natl Acad Sci 81:258–261CrossRefGoogle Scholar
  28. 28.
    Steinmetz CG, Xie P, Weiner H, Hurley TD (1997) Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure 5(5):701–711CrossRefGoogle Scholar
  29. 29.
    Chen C-H, Ferreira JCB, Gross ER, Mochly-Rosen D (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94(1):1–34CrossRefGoogle Scholar
  30. 30.
    Chen C-H, Budas GR, Churchill EN, Disatnik M-H, Hurley TD, Mochly-Rosen D (2008) Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321(5895):1493–1495CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Emmanuel A. Adeniji
    • 1
  • Fisayo A. Olotu
    • 1
  • Mahmoud E. S. Soliman
    • 1
  1. 1.Molecular Biocomputation and Drug Design Laboratory, School of Health SciencesUniversity of KwaZulu-NatalDurbanSouth Africa

Personalised recommendations